About the Authors
- Evelyn D. Olthof
-
Affiliation Intestinal Failure Unit, Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands
- Michelle W. Versleijen
-
Affiliation Department of Nuclear Medicine, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam, The Netherlands
- Getty Huisman–de Waal
-
Affiliations Intestinal Failure Unit, Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands, Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands
- Ton Feuth
-
Affiliation Department of Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands
- Wietske Kievit
-
Affiliation Department of Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands
- Geert J. A. Wanten
-
* E-mail: Geert.Wanten@radboudumc.nl
Affiliation Intestinal Failure Unit, Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands
Competing Interests
The authors of this manuscript have the following competing interests: GJAW has performed research and given presentations that were supported by fees from Geistlich and grants from Geistlich Pharma, Fresenius Kabi and Baxter. EDO, MWJV, GJHW, TF and WK declare no conflict of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: EDO MWJV GJAW. Performed the experiments: EDO MWJV GJHW. Analyzed the data: EDO TF WK. Contributed reagents/materials/analysis tools: GJAW. Wrote the paper: EDO MWJV GJHW TF WK GJAW.